Physician profile
Daniel C Daube
NPI 1174571509
$7,062.78
in general payments reported to CMS, 2019-2025
26 companies · $778 in 2025
The $778 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,538 · 2020: $394 · 2021: $348 · 2022: $1,818 · 2023: $913 · 2024: $1,275 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,815 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,815.37 |
| Education | $150.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,500.00 | 2019 | |
| Medical Device Business Services, INC. | $1,108.34 | 2022 | |
| Genzyme Corporation | $644.26 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $630.26 | 2021-2025 | Dupixent |
| Acclarent, INC | $544.09 | 2020-2023 | Trudi Nav Cable |
| Medtronic, INC. | $499.31 | 2023-2025 | Propel, Nuvent |
| Glaxosmithkline, LLC. | $355.96 | 2022-2025 | Nucala |
| Inspire Medical Systems, INC. | $314.57 | 2024 | Inspire |
| Depuy Synthes Sales INC. | $310.16 | 2020-2023 | Na |
| Intersect Ent, INC. | $194.15 | 2020-2021 | |
| Integra Lifesciences Corporation | $155.10 | 2022-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Neurent Medical Limited | $145.19 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Aerin Medical INC. | $124.50 | 2020-2024 | |
| Galderma Laboratories, L.P. | $105.54 | 2021-2024 | |
| Kls-Martin L.P. | $66.94 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $56.99 | 2025 | |
| Boston Scientific Corporation | $54.77 | 2021 | |
| Allergan, INC. | $44.03 | 2019-2021 | |
| Abbvie INC. | $36.71 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $35.60 | 2021-2023 | |
| Stryker Corporation | $29.23 | 2019-2022 | |
| Amgen INC. | $26.75 | 2025 | Tezspire |
| Organogenesis INC. | $26.03 | 2021 | |
| Paratek Pharmaceuticals, INC. | $22.35 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $18.92 | 2025 | Airsupra |
| Hikma Pharmaceuticals USA | $13.03 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Daube listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.